Article
Breaking Down Checkpoint Inhibitors
ONS member Virginia Bayer, BSN, RN, CCRP, research nurse supervisor at MD Anderson Cancer Center, joins ONS’s Barbara Lubejko, MS, RN, to discuss checkpoint inhibitors, their impact on patient care, what oncology nurses need to know about immunotherapies, and much more.
Related Topics
You May Also Like
Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
Clinical Educator Oncology Program Improves Adherence by 29%
Article
New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures
Article